Moneycontrol Be a Pro
Get App
you are here: HomeNewsBusiness
Last Updated : Sep 24, 2019 10:16 AM IST | Source: PTI

Biocon subsidiary acquires research facility from Pfizer Healthcare

Biocon Biologics has acquired research and development (R&D) capital assets of a 60,000-square feet research facility at Ticel Bio Park in Chennai, Biocon said in a statement.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Biotechnology major Biocon on Tuesday said its subsidiary has acquired a Chennai-based biological research facility from Pfizer Healthcare for an undisclosed amount.

Biocon Biologics has acquired research and development (R&D) capital assets of a 60,000-square feet research facility at Ticel Bio Park in Chennai, Biocon said in a statement.

“The high-end integrated R&D facility in Chennai will enable Biocon Biologics to expand its R&D capability and accelerate its journey towards meeting its strategic long-term goal of addressing the needs of millions of patients worldwide," Biocon Biologics CEO Christiane Hamacher said.

Close

This investment will allow the company to fast-forward development of its biosimilars from lab to pilot scale, he added.

The facility will house an early stage research and innovation centre, including a pilot scale R&D unit equipped with cell line development, drug product formulation laboratories and analytical R&D laboratories.

The facility is expected to be operational in a few months post qualification and will house over 250 scientists.

This acquisition provides Biocon Biologics a significant time advantage in comparison to setting up a greenfield R&D project and will accelerate the global development of its biosimilars portfolio, the company said.

At present, the company has an R&D centre at Bengaluru.

Biocon Biologics has a product pipeline of 28 molecules, including 11 with Mylan, few with Sandoz and rest on its own.

Biocon shares were trading 0.64 percent higher that their previous close at Rs 226.85 on the BSE.

Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on Sep 24, 2019 10:13 am
Loading...
Sections
Follow us on
Available On